NIH #3R44CA265446-02S1
Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data
- Amount
- $77K
- Period
- 2022-07-01 → 2025-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at ENVISAGENICS, INC.